China draws tens of thousands of patients from across the world, who access cutting-edge drugs and therapies at low cost.

The US Food and Drug Administration allows for American patients to buy medicines abroad, and bring them back to the US, in certain very limited circumstances.

Western pharma giants have discovered a massive new profit center, in buying global distribution rights from top Chinese labs, then aggressively marking up the price for patients in North America and Europe.